Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Pharma Mar (PHMMF) Return on Tangible Equity data is not available for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$241.35M |
|
$55.77M |
|
$100.14M |
|
$341.49M |
|
$94.63M |
|
$28.03M |
|
$51.53M |
|
$146.16M |
|
$195.33M |
|
$193.79M |
|
$195.33M |
|
-- |
|
| Cash Flow Statement Financials | |
$0.10M |
|
$-21.85M |
|
$-21.90M |
|
$64.64M |
|
$20.80M |
|
$-43.84M |
|
$0.17M |
|
$-12.30M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|